// App-Quantinova.ai

P-698 : Pituitary functioning gonadotroph adenomas (FGA-induced ovarian hyperstimulation syndrome (OHSS: results from tertiary neuroendocrine centres in the UK

Researchers

Presenter

  • N Papanikolaou

Principal Investigators

  • A Coulden

  • N Parker

  • S Lee

  • C Kelly

  • R Anderson

  • A Rees

  • J Cox

  • W Dhillo

  • K Meeran

  • M Al-Memar

  • N Karavitaki

  • C Jayasena

Medical Centers

  • NHS Forth Valley, Endocrinology, Larbert, United Kingdom

  • Imperial College Healthcare NHS Trust, Radiology, London, United Kingdom

  • Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

  • University of Edinburgh, Obstetrics and Gynaecology- Center for Reproductive health, Edinburgh, United Kingdom

  • Cardiff University School of Medicine, Cardiff, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom

  • Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom

  • Imperial College Healthcare NHS Trust, Radiology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Ovarian hyperstimulation syndrome

  • Hyperprolactinemia

  • Pituitary adenomas

  • Hyperthyroidism

  • Thyrotoxicosis

  • Prolactin-secreting pituitary adenoma

Biomarkers

  • Follicle-stimulating hormone

  • Estradiol

Drug/Treatment

  • Somatostatin

  • Alora

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved